Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
“Keep your cool.”
You must be confusing me with someone else.
A baseless assumption, that the former FDA experts have secretly left the company. You make this assumption because you cannot dispute my point that we have noted experts who know how to handle regulatory processes.
So you don’t disagree with me. Instead you focus on current/future trials and predict they will take a long time. You ignore the fact that at least one, and likely two, applications for AD will occur much sooner than trial outcomes. You are welcome to your opinions. I stated mine.
Uh huh. If you really think Missling is going to personally prepare the AD applications you are kidding yourself. He has noted experts, both employees and a contractor, that will do that.
Your claim, in general, that Missling does not delegate technical tasks to specialized staff is baseless. You have zero access to the company’s internal operations, and you have no clue who does what. Your negative, repetitive presumption that he tries to do everything is meaningless.
No, it’s not. The team on the field ultimately wins or loses the baseball game, not the team’s general manager. The general manager tries to put the right people in place and lets them do what they do. Missling has assembled a very good team and the trial data itself is the most important factor anyway.
Missling has little or no relevance to trial outcomes or regulatory outcomes. I don’t care about him much either way.
What truth? And why would it hurt me? I couldn’t care less about the current manipulated share price, whether it is 3 or 30. Completely irrelevant, except to those who let emotions affect their judgment. All that matters is the ultimate outcome of the application process, and the outcome of current and future trials.
Former pumper turned compulsive basher. Kind of like TooTall.
Uh oh. Looks like someone’s handler fed him some TA nonsense to regurgitate.
I have no idea what they do all day. I don’t work there. But I would guess, for example, that they perform tasks consistent with their job titles.
I also don’t know what the employees of any other company do all day. Nor do I care. I’ll leave that to their management.
I have no reason to “be skeptical.” I don’t have a bashing agenda that I need to support with speculative nonsense.
I love the logic of these assumptions. Since we are not privileged to know what a particular employee does on a daily basis, because we don’t work for the company, let’s assume that he does little, or nothing. Even better, since we don’t know his daily activities, let’s assume that he secretly resigned. What a brilliant exercise in deductive reasoning.
Orcas. They know more than they let on.
Cossacks, I suspect. Or possibly Freemasons.
Yes. But, as I noted, directing trades back and forth between “friendly” parties is not foolproof because they can get intercepted by third parties. As a result, at some point the mm’s end up with a short position that exceeds their risk parameters and they have to reduce it. Or, their naked short position (which they are quasi-permitted to carry) time period runs out and they have to buy and deliver shares.
Manipulation with algo trading can generally only be done on a relatively transitory basis in one direction. A percentage of the attempted churn trades (collusive parties trading back and forth to each other) get intercepted by others. The interest on the short positions is another factor.
The exception is when the suppression actually damages a company’s financial position, i.e., they are forced to keep issuing shares at lower and lower prices and even sometimes run out of cash. That will not happen here because they would have to keep the price consistently suppressed for several years. Now you know why Missling always keeps a large cash cushion. He knows all too well how it works.
As usual, you revert to personal attacks and labels. Your initial comment was that the CHMP might not accept the application because they, all of a sudden, despite having already seen the data in a summary review, deem it unlikely to be approved.
I was merely pointing out that this is a pessimistic, and relatively unlikely, premise.
You are confusing me with those who are “WGT”. Which term you categorically assign to anyone who even slightly questions any opinion that you put forth.
This doesn’t make sense to me. Why, and how, would the CHMP conclude, before the application is completed/accepted, that the substantive results are not good enough? Any perceived deficiencies in the application, it would seem to me, would be procedural/technical as opposed to substantive, no?
Barring some clearly fatal flaw in the trial methodology or the validity of the data, or a fatal error in the statistical analysis, the agency will accept the application and decide based on substance, right?
There was more buying volume than selling today and the last few candles were green also. Yet the stock closed down 6%+. A neat trick but not unusual. I suspect they may be running out of ammo. Not literally. Of course they have more funds, if they choose. I mean they may be getting antsy from a risk-reward standpoint. No guarantees. Such are the whims of the mm-hedge fund traders. Although one of their backdrops is time. So the equation is really “risk-reward-time”. This is why, when they see a presentation with nothing new, and no firm prediction of imminent news, they move the stock down. They think they will get out of the trade later, while they to try to play on investors’ patience.
As the hedgie agents like to say, “kick the can down the road.”
None of this has any bearing on actual substance. It’s a game.
These posts are so much more stupid than anything the so called “pumpers” put forth. Oddly (?) nobody ever complains about this. Surely you could come up with something more intelligent? Or are you relying on repitition?
Yep. They are manipulating it to an inflection point. And they will be laughing over their martinis at Harry’s about the dupes who held for years only to sell at the low right before “Thank you for playing, we have a lovely door prize for you on your way out. You paid for our drinks.”
Good explanation. What would be common reasons, if any, that the interested parties would decline participation in the trial?
Trust me, I find your words far more meaningless than Missling’s.
They may be flushing some people out who are unwisely on margin or have stop loss orders set but otherwise I think the shares are mainly being churned or they are coming from bandwagon shorts jumping in.
If they are committed then I think the medical staff can order whatever meds they want, no?
Thank you, your opinion is less than meaningless to me.
Thank you for that reasoned comment. Just what I was looking for. Maybe true, maybe not, but it is at least something other than a guess, or wishful thinking.
The hedges and mm’s are actively trying to flush people out. It’s rather obvious. Getting close to reloading some trading shares.
Thanks, Boi. I wonder if some of those patients even have a choice?
I’m not sure why recruiting a few dozen schizo patients would take a long time. Unless someone has a plausible reason for that then I would assume that the FDA website entry for study completion date was not revised after enrollment commenced a few months earlier than expected?
And how does that affect your life, exactly?
Clearly the EMA application is the most important issue. But I asked a simple question about a different trial, for general information purposes.
Yeah, those dates are fairly meaningless.
No. My investment doesn’t need to be saved. Just basic curiosity.
Anyone have an educated hypothesis of how long it will AVXL to fully enroll the schizo trial? Seems to me it should be pretty quick, with plenty of potential patients. Will these be institutionalized patients or outpatients?
Exactly correct. Rate cuts at this point are simply a harmful political stunt.
I’m aware of your opinion on Missling. I disagree. He’s far from perfect but the merits of the trial results and his people’s ability to submit effective applications are all that matter at this point.
To each his own. We have imperfect information but I like our odds at this price. And I don’t care if they take it down further. To me it is artificial.
The fact remains that it is a near certainty that an EMA application will be filed, and that the EMA initially viewed the trial results favorably. Your focus on the possibility that it won’t be accepted is unduly negative, and none of this warrants the attack in the share price.
The AD trial certainly did not fail. The EMA clearly agrees with me. No other trial has ever had a better combination of efficacy and safety.
Yet to some of you, this all somehow justifies a two year low in the stock price? Not buying it. The stock is being manipulated currently precisely because, after all of this time, applications for approval are imminent. The frivolous lawsuit is part of that process, as is the presence here of about a dozen posters who attack the company all day long, every day, as if it’s their job.
He thinks he’s fooling someone with his fake long position while posting 30 troll messages per day for several years. It’s pretty funny, actually. Him and several others. And they claim that Missling has no credibility. lol
That’s your talking point now? That he lied about being greenlighted for an application for full approval by the EMA and he has no intention of filing? And the FDA’s new guidance for CNS drugs—which almost seems as if it was tailored to AVXL’s trial results—is somehow a non-sequitur? Good luck with that.